P-108

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP-108
Drug Alias Nameanticancer peptide (Georgetown University)P-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeorgetown University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeorgetown University
Active IndicationsN/A
Inactive IndicationsBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A